Inflammatory markers and the risk of hip fracture: The women's health initiative

Journal of Bone and Mineral Research

Volumn 27, Issue 5, 2012, Pages 1167-1176

  Barbour, Kamil E ^a   Boudreau, Robert ^a   Danielson, Michelle E ^a   Youk, Ada O ^a   Wactawski Wende, Jean ^b   Greep, Nancy C ^c   LaCroix, Andrea Z ^d   Jackson, Rebecca D ^e   Wallace, Robert B ^f   Bauer, Douglas C ^d   Allison, Matthew A ^g   Cauley, Jane A ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c JOHN WAYNE CANCER INSTITUTE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CYTOKINES; HIP FRACTURES; INFLAMMATION; NESTED CASE CONTROL; OSTEOPOROSIS; WOMEN

Indexed keywords

25 HYDROXYVITAMIN D; CYSTATIN C; INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BODY MASS; BONE RADIOGRAPHY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; POSTMENOPAUSE; WOMEN'S HEALTH;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HIP FRACTURES; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; RISK FACTORS; WOMEN'S HEALTH;

EID: 84859903489     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1559     Document Type: Article

References (59)

1. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE., Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004; 53 (3): 693-700.
2. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R., Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999; 106 (5): 506-12.
3. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, Penninx B, Pahor M, Wallace R, Havlik RJ., Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999; 47 (6): 639-46.
4. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE., Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology. 2002; 59 (3): 371-8.
5. McGeer PL, McGeer EG., Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging. 2001; 22 (6): 799-809.
6. Kritchevsky SB, Cesari M, Pahor M., Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res. 2005; 66 (2): 265-75.
7. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB., Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004; 351 (25): 2599-610.
8. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R., Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology. 1995; 136 (7): 3054-61.
9. Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R., T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. J Bone Miner Res. 2001; 16 (2): 328-37.
10. Kostenuik PJ, Shalhoub V., Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Curr Pharm Des. 2001; 7 (8): 613-35.
11. Cenci S, Toraldo G, Weitzmann MN, Roggia C, Gao Y, Qian WP, Sierra O, Pacifici R., Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci U S A. 2003; 100 (18): 10405-10.
12. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC., Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992; 257 (5066): 88-91.
13. Cauley JA, Danielson ME, Boudreau RM, Forrest KY, Zmuda JM, Pahor M, Tylavsky FA, Cummings SR, Harris TB, Newman AB., Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res. 2007; 22 (7): 1088-95.
14. Khosla S, Amin S, Orwoll E., Osteoporosis in men. Endocr Rev. 2008; 29 (4): 441-64.
15. Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH., Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med. 2002; 162 (19): 2217-22.
16. Schurch MA, Rizzoli R, Mermillod B, Vasey H, Michel JP, Bonjour JP., A prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Miner Res. 1996; 11 (12): 1935-42.
17. Aderka D, Engelmann H, Shemer-Avni Y, Hornik V, Galil A, Sarov B, Wallach D., Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res. 1992; 11 (3): 157-9.
18. Honda M, Yamamoto S, Cheng M, Yasukawa K, Suzuki H, Saito T, Osugi Y, Tokunaga T, Kishimoto T., Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol. 1992; 148 (7): 2175-80.
19. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF., Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A. 1992; 89 (11): 4845-9.
20. Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, Rossouw JE., The Women's Health Initiative recruitment methods and results. Ann Epidemiol. 2003; 13 (9 Suppl): S18-77.
21. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, Johnson KC, Proulx-Burns L, Pastore L, Criqui M, Daugherty S., Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol. 2003; 13 (9 Suppl): S122-8.
22. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T., Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999; 9 (3): 178-87.
23. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, Perri MG, Sheps DS, Pettinger MB, Siscovick DS., Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med. 2002; 347 (10): 716-25.
24. Hays RD, Sherbourne CD, Mazel RM., The RAND 36-Item Health Survey 1.0. Health Econ. 1993; 2 (3): 217-27.
25. Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, Masaki K, Murray A, Newman AB., Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc. 2005; 53 (8): 1321-30.
26. Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang CY, Stein E, Prentice RL., Implementation of the Women's Health Initiative study design. Ann Epidemiol. 2003; 13 (9 Suppl): S5-17.
27. Freeman RK, Bateman BG, Goebelsmann U, Arce JJ, James J., Clinical experience with the amniotic fluid lecithin-sphingomyelin ratio. II. The L-S ratio in "stressed pregnancies ". Am J Obstet Gynecol. 1974; 119 (2): 239-42.
28. Goebelsmann U, Arce JJ, Thorneycroft IH, Mishell DR Jr., Serum testosterone concentrations in women throughout the menstrual cycle and following HCG administration. Am J Obstet Gynecol. 1974; 119 (4): 445-52.
29. Probst-Hensch NM, Ingles SA, Diep AT, Haile RW, Stanczyk FZ, Kolonel LN, Henderson BE., Aromatase and breast cancer susceptibility. Endocr Relat Cancer. 1999; 6 (2): 165-73.
30. Stanczyk FZ, Shoupe D, Nunez V, Macias-Gonzales P, Vijod MA, Lobo RA., A randomized comparison of nonoral estradiol delivery in postmenopausal women. Am J Obstet Gynecol. 1988; 159 (6): 1540-6.
31. Rinaldi S, Geay A, Dechaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, Shore RE, Riboli E, Toniolo P, Kaaks R., Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev. 2002; 11 (10 Pt 1): 1065-71.
32. Sodergard R, Backstrom T, Shanbhag V, Carstensen H., Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem. 1982; 16 (6): 801-10.
33. Vermeulen A, Verdonck L, Kaufman JM., A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999; 84 (10): 3666-72.
34. Cauley JA, Lacroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, Lee JS, Jackson RD, Robbins JA, Wu C, Stanczyk FZ, LeBoff MS, Wactawski-Wende J, Sarto G, Ockene J, Cummings SR., Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008; 149 (4): 242-50.
35. Penninx BW, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, Rubin S, Nevitt M, Visser M, Harris T, Pahor M., Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc. 2004; 52 (7): 1105-13.
36. Penninx BW, Geerlings SW, Deeg DJ, van Eijk JT, van Tilburg W, Beekman AT., Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry. 1999; 56 (10): 889-95.
37. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM., Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993; 341 (8837): 72-5.
38. Pacifici R., Estrogen deficiency, T cells and bone loss. Cell Immunol. 2008; 252 (1-2): 68-80.
39. Maggio M, Ceda GP, Lauretani F, Bandinelli S, Corsi AM, Giallauria F, Guralnik JM, Zuliani G, Cattabiani C, Parrino S, Ablondi F, Dall'aglio E, Ceresini G, Basaria S, Ferrucci L., SHBG, sex hormones, and inflammatory markers in older women. J Clin Endocrinol Metab. 2011; 96 (4): 1053-9.
40. Stork S, Bots ML, Grobbee DE, van der Schouw YT., Endogenous sex hormones and C-reactive protein in healthy postmenopausal women. J Intern Med. 2008; 264 (3): 245-53.
41. Mehio-Sibai A, Feinleib M, Sibai TA, Armenian HK., A positive or a negative confounding variable? A simple teaching aid for clinicians and students. Ann Epidemiol. 2005; 15 (6): 421-3.
42. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G., Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005; 68 (1): 237-45.
43. Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC., Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2009; 53 (4): 596-605.
44. Fried L, Solomon C, Shlipak M, Seliger S, Stehman-Breen C, Bleyer AJ, Chaves P, Furberg C, Kuller L, Newman A., Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004; 15 (12): 3184-91.
45. Bertani T, Abbate M, Zoja C, Corna D, Perico N, Ghezzi P, Remuzzi G., Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol. 1989; 134 (2): 419-30.
46. Le Hir M, Haas C, Marino M, Ryffel B., Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. Lab Invest. 1998; 78 (12): 1625-31.
47. Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG., Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int. 2007; 71 (3): 239-44.
48. Ensrud KE, Lui LY, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR., Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med. 2007; 167 (2): 133-9.
49. LaCroix AZ, Lee JS, Wu L, Cauley JA, Shlipak MG, Ott SM, Robbins J, Curb JD, Leboff M, Bauer DC, Jackson RD, Kooperberg CL, Cummings SR., Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc. 2008; 56 (8): 1434-41.
50. Fried LF, Biggs ML, Shlipak MG, Seliger S, Kestenbaum B, Stehman-Breen C, Sarnak M, Siscovick D, Harris T, Cauley J, Newman AB, Robbins J., Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol. 2007; 18 (1): 282-6.
51. Clowes JA, Riggs BL, Khosla S., The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev. 2005; 208: 207-27.
52. Abrahamsen B, Bonnevie-Nielsen V, Ebbesen EN, Gram J, Beck-Nielsen H., Cytokines and bone loss in a 5-year longitudinal study-hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study. J Bone Miner Res. 2000; 15 (8): 1545-54.
53. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G., Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab. 2008; 93 (5): 1952-8.
54. Gertz ER, Silverman NE, Wise KS, Hanson KB, Alekel DL, Stewart JW, Perry CD, Bhupathiraju SN, Kohut ML, Van Loan MD., Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation. J Clin Densitom. 2010; 13 (3): 277-82.
55. Scheidt-Nave C, Bismar H, Leidig-Bruckner G, Woitge H, Seibel MJ, Ziegler R, Pfeilschifter J., Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab. 2001; 86 (5): 2032-42.
56. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR., Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 1986; 319 (6053): 516-8.
57. Johnson RA, Boyce BF, Mundy GR, Roodman GD., Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology. 1989; 124 (3): 1424-7.
58. Jilka RL., Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. Bone. 1998; 23 (2): 75-81.
59. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A. 1993; 90 (24): 11924-8.